Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression

Transfusion

Volumn 57, Issue 2, 2017, Pages 280-288

  Satake, Masahiro ^a   Matsubayashi, Keiji ^a   Hoshi, Yuji ^a   Taira, Rikizo ^b   Furui, Yasumi ^b   Kokudo, Norihiro ^c   Akamatsu, Nobuhisa ^c   Yoshizumi, Tomoharu ^d   Ohkohchi, Nobuhiro ^e   Okamoto, Hiroaki ^f   Miyoshi, Masato ^g   Tamura, Akinori ^h,i   Fuse, Kyoko ^j   Tadokoro, Kenji ^b  

^a SUWA RED CROSS HOSPITAL   (Japan)

^b Japanese Red Cross Blood Service Headquarters   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^h NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ Tamura Medical Clinic   (Japan)

^j NIIGATA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; FRESH FROZEN PLASMA; RIBAVIRIN; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ABDOMINAL INJURY; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGINA PECTORIS; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; BURKITT LYMPHOMA; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; EPIDURAL ABSCESS; ERYTHROCYTE; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HYPERTRANSAMINASEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; INFECTIOUS DOSE; JAPAN; LIVER CELL CARCINOMA; LIVER INJURY; LIVER TRANSPLANTATION; LUNG ABSCESS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NONALCOHOLIC FATTY LIVER; NONHODGKIN LYMPHOMA; PANCYTOPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMONIA; PRIMARY BILIARY CIRRHOSIS; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; RECIPIENT; SEPSIS; STOMACH CANCER; THROMBOCYTE; UNSTABLE ANGINA PECTORIS; VERY ELDERLY; VIRAL CLEARANCE; VIRAL CONTAMINATION; VIREMIA; VIRUS INFECTIVITY; VIRUS TRANSMISSION; YOUNG ADULT; BLOOD; CLINICAL TRIAL; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSIVE TREATMENT; TRANSMISSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; FEMALE; HEMATOLOGIC NEOPLASMS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 85011708624     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13994     Document Type: Article

References (38)

1. Dalton H, Bendall R, Ijaz S, et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698–709.
2. Meng XJ. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011;161:23–30.
3. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997;94:9860–5.
4. Takahashi K, Kitajima N, Abe N, et al. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 2004;330:501–5.
5. Izopet J, Dubois M, Bertagnoli S, et al. Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg Infect Dis 2012;18:1274–81.
6. Takahashi M, Tamura K, Hoshino Y, et al. A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol 2010;82:271–81.
7. Takeda H, Matsubayashi K, Sakata H, et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010;99:307–13.
8. Takahashi M, Okamoto H. Features of hepatitis E virus infection in humans and animals in Japan. Hepatol Res 2014;44:43–58.
9. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004;44:934–40.
10. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48:1368–75.
11. National Institute of Infectious Diseases. Recent increase in hepatitis E. Infectious Agents Surveillance Report 2016;37:134–6.
12. Vollmer T, Diekmann J, Johne R, et al. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012;50:2708–13.
13. Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need [comment]? Lancet 2014;384:1729–30.
14. Minagi T, Okamoto H, Ikegawa M, et al. Hepatitis E virus in donor plasma collected in Japan. Vox Sang 2016;111:242–6.
15. Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol 2002;40:3209–18.
16. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37:113–20.
17. Fuse K, Matsuyama Y, Moriyama M, et al. Late onset post-transfusion hepatitis E developing during chemotherapy for acute promyelocytic leukemia. Intern Med 2015;54:657–61.
18. Inagaki Y, Oshiro Y, Tanaka T, et al. A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan. EBioMedicine 2015;2:1607–12.
19. Tanaka T, Akamatsu N, Sakamoto Y, et al. Treatment with ribavirin for chronic hepatitis E following living donor liver transplantation: a case report. Hepatol Res 2016;46:1058–9.
20. Miyoshi M, Kakinuma S, Tanabe Y, et al. A case of chronic hepatitis E infection in a persistently immunosuppressed patient unable to be eliminated after ribavirin therapy. Intern Med 2016;55:2811–7.
21. Kurihara T, Yoshizumi T, Itoh S, et al. Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report. Surg Case Rep 2016;2:32.
22. Kimura Y, Gotoh A, Katagiri S, et al. Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes. Blood Transfus 2014;12:103–6.
23. Huzly D, Umhau M, Bettinger D, et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill 2014;19: pii: 20812.
24. Taira R, Satake M, Momose S, et al. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion 2013;53:1393–404.
25. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766–73.
26. Takahashi M, Tanaka T, Takahashi H, et al. Hepatitis E virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol 2010;48:1112–25.
27. Huang SJ, Liu XH, Zhang J, et al. Protective immunity against HEV. Curr Opin Virol 2014;5:1–6.
28. Yin X, Ambardekar C, Lu Y, et al. Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses. J Virol 2016;90:4232–42.
29. Drebber U, Odenthal M, Aberle SW, et al. Hepatitis E in liver biopsies from patients with acute hepatitis of clinically unexplained origin. Front Physiol 2013;4:351.
30. Suneetha PV, Pischke S, Schlaphoff V, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012;55:695–708.
31. Srivastava R, Aggarwal R, Jameel S, et al. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol 2007;20:56–65.
32. Srivastava R, Aggarwal R, Bhagat MR, et al. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepat 2008;15:910–6.
33. Majumdar M, Ratho RK, Chawla Y, et al. Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E. J Clin Virol 2015;73:8–13.
34. Lau JY, Sallie R, Fang JW, et al. Detection of hepatitis E virus genome and gene products in two patients with fulminant hepatitis E. J Hepatol 1995;22:605–10.
35. Cobden I, James OF. A biphasic illness associated with acute hepatitis A virus infection. J Hepatol 1986;2:19–23.
36. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481–9.
37. Péron JM, Abravanel F, Guillaume M, et al. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. Liver Int 2016;36:328–33.
38. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010;139:1612–8.